Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CorMedix (CRMD) Treasury Shares: 2023-2024

  • CorMedix's Treasury Shares was N/A to $291,494 in Q4 2024 from the same period last year, while for Dec 2024 it was $291,494, marking a year-over-year change of. This contributed to the annual value of $291,494 for FY2024, which is N/A change from last year.
  • Per CorMedix's latest filing, its Treasury Shares stood at $291,494 for Q4 2024, which was up 181.00% from $103,735 recorded in Q3 2023.
  • CorMedix's 5-year Treasury Shares high stood at $291,494 for Q4 2024, and its period low was $103,735 during Q3 2023.
  • Over the past 2 years, CorMedix's median Treasury Shares value was $197,614 (recorded in 2023), while the average stood at $197,614.